SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-002971
Filing Date
2021-03-05
Accepted
2021-03-05 16:50:18
Documents
2
Period of Report
2021-03-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3568
2 ex24kollender20210305.txt EX-24 4206
  Complete submission text file 0001179110-21-002971.txt   9225
Mailing Address C/O QUAKER BIOVENTURES, CIRA CENTRE 2929 ARCH STREET, 3RD FLOOR PHILADELPHIA PA 19104-2868
Business Address
Kollender Richard S (Reporting) CIK: 0001415666 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37569 | Film No.: 21719168

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Issuer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
SIC: 2834 Pharmaceutical Preparations